HomeNewsBusinessAlmost two-thirds of Indian consumers ate healthy biscuits in last 6 months: Mintel survey

Almost two-thirds of Indian consumers ate healthy biscuits in last 6 months: Mintel survey

Even before the pandemic, the research highlighted that almost one-third (30%) of consumers said they find biscuits/cookies that improve immunity to be appealing.

July 29, 2020 / 18:47 IST
Story continues below Advertisement

The COVID-19 pandemic seems to have changed eating preferences when it comes to biscuits.

As many as 63 percent or two-thirds of Indian consumers have eaten healthy biscuits such as multigrain, high-fibre, light, and low/no sugar varieties in the last six months, a recent survey conducted by Mintel, a global market intelligence agency, revealed. 

Story continues below Advertisement

 The survey showed, that prior to the pandemic almost one-third (30 percent) of consumers said they find biscuits/cookies that improve immunity to be appealing. This number goes up to 41 percent for consumers in the South and 35 percent among consumers aged 25-34 across India.

Other health-related biscuit features that appeal to Indian consumers are energy-boosting (36 percent) and balanced nutrition (33 percent).

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show